THE TRANSIT RATE OF DIFFERENT-SIZED MODEL DOSAGE FORMS THROUGH THE HUMAN COLON AND THE EFFECTS OF A LACTULOSE-INDUCED CATHARSIS

被引:66
作者
WATTS, PJ
BARROW, L
STEED, KP
WILSON, CG
SPILLER, RC
MELIA, CD
DAVIES, MC
机构
[1] UNIV NOTTINGHAM, DEPT PHARMACEUT SCI, NOTTINGHAM NG7 2RD, ENGLAND
[2] QUEENS MED CTR, DEPT PHYSIOL & PHARMACOL, NOTTINGHAM NG7 2UH, ENGLAND
[3] QUEENS MED CTR, DEPT THERAPEUT, NOTTINGHAM NG7 2UH, ENGLAND
关键词
GAMMA-SCINTIGRAPHY; TC-99M]TECHNETIUM; IN-111]INDIUM; COLON TRANSIT; TABLETS; MICROPARTICLES; LACTULOSE;
D O I
10.1016/0378-5173(92)90245-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gamma scintigraphy has been used to compare the colonic transit rate of different sizes of radiolabelled model dosage forms in healthy human subjects. Studies simultaneously compared the ascending colon residence time of In-111-labelled 0.2 mm ion-exchange resin particles and Tc-99m-labelled 5 or 8.4 mm non-disintegrating tablets. Under normal conditions, no difference was observed between the rate of transit through the ascending colon of 0.2 mm particles vs 5 mm tablets (n = 11) or 0.2 mm particles vs 8.4 mm tablets (n = 10). The mean period of residence of 50% of the administered 0.2 mm particles in the ascending colon was 11.0 +/- 4.0 h (n = 21). Coadministration of the laxative, lactulose, to subjects receiving the 0.2 and 5 mm particles significantly accelerated colonic transit. Under these conditions, the ascending colon residence of the 0.2 mm resin was significantly shorter than for the 5 mm tablets, although the magnitude of the effect was small.
引用
收藏
页码:215 / 221
页数:7
相关论文
共 17 条
[1]   RELATIONSHIP BETWEEN THE RATE OF APPEARANCE OF OXPRENOLOL IN THE SYSTEMIC CIRCULATION AND THE LOCATION OF AN OXPRENOLOL OROS 16/260 DRUG DELIVERY SYSTEM WITHIN THE GASTROINTESTINAL-TRACT AS DETERMINED BY SCINTIGRAPHY [J].
DAVIS, SS ;
WASHINGTON, N ;
PARR, GD ;
SHORT, AH ;
JOHN, VA ;
LLOYD, P ;
WALKER, SM .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (04) :435-443
[2]   TRANSIT OF PHARMACEUTICAL DOSAGE FORMS THROUGH THE SMALL-INTESTINE [J].
DAVIS, SS ;
HARDY, JG ;
FARA, JW .
GUT, 1986, 27 (08) :886-892
[3]   COLONIC RELEASE OF 5-AMINO SALICYLIC-ACID FROM AN ORAL PREPARATION IN ACTIVE ULCERATIVE-COLITIS [J].
DEW, MJ ;
RYDER, REJ ;
EVANS, N ;
EVANS, BK ;
RHODES, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :185-187
[4]   COLON-SPECIFIC DRUG DELIVERY [J].
FRIEND, DR .
ADVANCED DRUG DELIVERY REVIEWS, 1991, 7 (01) :149-199
[5]   ENEMA VOLUME AND SPREADING [J].
HARDY, JG ;
LEE, SW ;
CLARK, AG ;
REYNOLDS, JR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 31 (1-2) :151-155
[6]   DRUG DELIVERY TO THE PROXIMAL COLON [J].
HARDY, JG ;
WILSON, CG ;
WOOD, E .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (12) :874-877
[7]   VALIDITY OF THE GEOMETRIC MEAN CORRECTION IN THE QUANTIFICATION OF WHOLE BOWEL TRANSIT [J].
HARDY, JG ;
PERKINS, AC .
NUCLEAR MEDICINE COMMUNICATIONS, 1985, 6 (04) :217-224
[8]  
Ikesue K, 1991, P INT S CONTROL REL, V18, P580
[9]  
JARNEROT G, 1989, DRUGS, V37, P73
[10]   Simplified Assessment of Segmental Colonic Transit [J].
Metcalf, Amanda M. ;
Phillips, Sidney F. ;
Zinsmeister, Alan R. ;
MacCarty, Robert L. ;
Beart, Robert W. ;
Wolff, Bruce G. .
GASTROENTEROLOGY, 1987, 92 (01) :40-47